<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">43584</article-id><article-id pub-id-type="doi">10.7554/eLife.43584</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-125926"><name><surname>Zhang</surname><given-names>Wenjuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109084"><name><surname>Falcon</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125927"><name><surname>Murzin</surname><given-names>Alexey G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125928"><name><surname>Fan</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32462"><name><surname>Crowther</surname><given-names>R Anthony</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-64956"><name><surname>Goedert</surname><given-names>Michel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3361"><name><surname>Scheres</surname><given-names>Sjors HW</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0462-6540</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Structural Studies</institution>, <institution>MRC Laboratory of Molecular Biology</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-6967"><name><surname>Grigorieff</surname><given-names>Nikolaus</given-names></name><role>Reviewing editor</role><aff><institution>Janelia Research Campus, Howard Hughes Medical Institute</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>mg@mrc-lmb.cam.ac.uk</email> (MG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>scheres@mrc-lmb.cam.ac.uk</email> (SS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>05</day><month>02</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e43584</elocation-id><history><date date-type="received"><day>12</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>31</day><month>01</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Zhang et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Zhang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-43584-v1.pdf"/><abstract><p>Assembly of microtubule-associated protein tau into filamentous inclusions underlies a range of neurodegenerative diseases. Tau filaments adopt different conformations in Alzheimer's and Pick's diseases. Here, we used cryo- and immuno- electron microscopy to characterise filaments that were assembled from recombinant full-length human tau with four (2N4R) or three (2N3R) microtubule-binding repeats in the presence of heparin. 2N4R tau assembles into multiple types of filaments, and the structures of three types reveal similar 'kinked hairpin' folds, in which the second and third repeats pack against each other. 2N3R tau filaments are structurally homogeneous, and adopt a dimeric core, where the third repeats of two tau molecules pack in a parallel manner. The heparin-induced tau filaments differ from those of Alzheimer's or Pick's disease, which have larger cores with different repeat compositions. Our results illustrate the structural versatility of amyloid filaments, and raise questions about the relevance of in vitro assembly.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_U105184291</award-id><principal-award-recipient><name><surname>Goedert</surname><given-names>Michel</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>European Union</institution></institution-wrap></funding-source><award-id>Joint Programme- Neurodegeneration Research REfrAME</award-id><principal-award-recipient><name><surname>Goedert</surname><given-names>Michel</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UP_A025_1013</award-id><principal-award-recipient><name><surname>Scheres</surname><given-names>Sjors HW</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>European Union</institution></institution-wrap></funding-source><award-id>IMPRIND-116060</award-id><principal-award-recipient><name><surname>Goedert</surname><given-names>Michel</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Michel Goedert, Reviewing editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf3"><p>Sjors HW Scheres, Reviewing editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>EM maps have been submitted to EMDB, under codes 4563, 4564, 4565 and 4566Atomic models have been submitted to PDB under codes 6QJH, 6QJM, 6QJP and 6QJQRaw EM images have been submitted to EMPIAR under codes  10242 and 10243</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Zhang et al</collab></person-group><year iso-8601-date="2019">2019</year><source>Cryo-EM reconstruction of heparin-induced 2N3R tau filaments</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pdbe/emdb/empiar/">https://www.ebi.ac.uk/pdbe/emdb/empiar/</ext-link><comment>10242</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Zhang et al</collab></person-group><year iso-8601-date="2019">2019</year><source>Cryo-EM reconstruction of heparin-induced 2N4R tau filaments</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pdbe/emdb/empiar/">https://www.ebi.ac.uk/pdbe/emdb/empiar/</ext-link><comment>10243</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-43584-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>